HPV Highly Resistant to Standard Medical Cleaning Processes
Journal of Antimicrobial Chemotherapy.
Researchers introduced particles of the HPV 16 strain to 11 common clinical disinfectants used as sterilizers in medical facilities. According to the National Cancer Institute, HPV 16 is one of two HPV strains that cause approximately 70 percent of all cervical cancers. Approximately 85 percent of all anal cancers are caused by HPV 16.
They found the virus to be resistant to glutaraldehyde and ortho-phthalaldehyde.
Researchers suggest disinfectant policy changes are needed to address the highly-resistant virus.
More Articles on Infection Control:
CLABSI Rates Decrease With Presence of Unit Quality Nurse
Decision-Making, Lack of Knowledge Tank Hand Hygiene Compliance
HAI Transmission Through Clothing: 6 Ways to Reduce
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
New From Becker's Infection Control & Clinical Quality
CMS Delays Quality Reporting Measure ASC-11 ImplementationRead Now
- Randy Oostra, Michael Sanborn, and Dr. Michael Schatzlein to Speak at Becker's Hospital Meeting
- 6 Questions to Help Identify the Best Candidates for Hire
- Medical Device Industry leader to Know: Guntmar Eisen of Paradigm Spine
- Unique Methods of Payment: Opportunities for ASCs?
- ASC M&A Activity: 4 Big Trends for 2014 From HealthCare Appraisers